Elaine J. Heron, a director, bought PalvelLA Therapeutics ($PVLA) shares worth $300,000 in one open market transaction on February 27, 2026, ranking 1,150th among insiders for purchase volume. She also purchased Vaxart ($VXRT) shares totaling about $16,000 across two trades, most recently on November 17, 2025, ranking 3,998th. With no open market sales in the past year, her buys trail the average of $1.5 million across 4,983 insiders averaging 3.3 transactions each.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | PALVELLA THERAPEUTICS, INC. | $PVLA | HERON ELAINE J | Director | P | Common Stock | 2400 | $125.00 | 53,691.0000 | 11,836,490 | 4.68% | 0.02% |
| Nov. 17, 2025 | Vaxart, Inc. | $VXRT | HERON ELAINE J | Director | P | Common Stock | 23217 | $0.39 | 79,783.0000 | 240,069,844 | 41.04% | 0.01% |
| Nov. 17, 2025 | Vaxart, Inc. | $VXRT | HERON ELAINE J | Director | P | Common Stock | 16783 | $0.41 | 96,566.0000 | 240,069,844 | 21.04% | 0.01% |
| June 13, 2025 | Vaxart, Inc. | $VXRT | HERON ELAINE J | Director | A | Common Stock | 16000 | $0.00 | 56,566.0000 | 227,949,245 | 39.44% | 0.01% |
| June 13, 2025 | Vaxart, Inc. | $VXRT | HERON ELAINE J | Director | A | Stock Option (right to buy) | 95400 | $0.00 | 95,400.0000 | 227,949,245 | 9999.99% | 0.04% |
| June 10, 2025 | PALVELLA THERAPEUTICS, INC. | $PVLA | HERON ELAINE J | Director | A | Non-Qualified Stock Option (right to buy) | 12350 | $0.00 | 12,350.0000 | 11,018,747 | 9999.99% | 0.11% |
| Dec. 13, 2024 | PALVELLA THERAPEUTICS, INC. | $PVLA | HERON ELAINE J | Director | A | Stock Option (right to buy) | 24700 | $0.00 | 24,700.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | Vaxart, Inc. | $VXRT | HERON ELAINE J | Director | A | Stock Option (right to buy) | 95400 | $0.00 | 95,400.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | Vaxart, Inc. | $VXRT | HERON ELAINE J | Director | A | Common Stock | 16000 | $0.00 | 40,566.0000 | 0 | 65.13% | 0.00% |
| June 3, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | HERON ELAINE J | Director | M | Common Stock | 5047 | $63.10 | 101,888.0000 | 191,595,000 | 5.21% | 0.00% |
| June 3, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | HERON ELAINE J | Director | M | Stock Option (Right to Buy Common Stock) | 5047 | $0.00 | 0.0000 | 191,595,000 | 100.00% | 0.00% |
| June 3, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | HERON ELAINE J | Director | F | Common Stock | 4168 | $76.41 | 97,720.0000 | 191,595,000 | 4.09% | 0.00% |
| May 21, 2024 | BIOMARIN PHARMACEUTICAL INC | $BMRN | HERON ELAINE J | Director | A | Common Stock | 4720 | $0.00 | 96,841.0000 | 191,595,000 | 5.12% | 0.00% |
| May 23, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | HERON ELAINE J | Director | A | Common Stock | 4190 | $0.00 | 92,121.0000 | 188,963,000 | 4.77% | 0.00% |
| May 12, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | HERON ELAINE J | Director | M | Common Stock | 8500 | $67.81 | 94,068.0000 | 188,963,000 | 9.93% | 0.00% |
| May 12, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | HERON ELAINE J | Director | F | Common Stock | 6137 | $93.93 | 87,931.0000 | 188,963,000 | 6.52% | 0.00% |
| May 12, 2023 | BIOMARIN PHARMACEUTICAL INC | $BMRN | HERON ELAINE J | Director | M | Stock Option (Right to Buy Common Stock) | 8500 | $0.00 | 0.0000 | 188,963,000 | 100.00% | 0.00% |